
Quiz|Articles|July 12, 2026
Dermatology Times Spot Test: July 12, 2026
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- A recurring quiz series is framed as a weekly mechanism to evaluate and reinforce dermatology knowledge across foundational concepts and new developments.
- This week’s clinical-news focus centers on Evommune updates relevant to chronic spontaneous urticaria.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.
Advertisement
Welcome to Dermatology Times' Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we’ll focus on the latest news from
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
What was the primary outcome of Evommune's phase 2b trial of EVO756 in CSU?
Which mechanism of action best describes EVO756?
Approximately how many patients were enrolled in this phase 2b trial?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: PDRN Serums
2
The Gut-Skin Axis: New Evidence Links Microbiota to Skin Disease via Inflammatory Cytokines
3
Building a More Resilient Independent Dermatology Practice
4
5 Dermatology Approvals to Know from the First Half of 2026
5












